The 27th International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2016)
The 27th International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2016) will be held in Guangzhou, China, from 13–16 November 2016.
Photo Credit: Rui Wang/Getty Imgaes
The 27th International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2016) will be held in Guangzhou, China, from 13–16 November 2016.
Since 1987 the PBA has organized symposia all over the world and for the first time in its history the symposium will take place in Guangzhou, China. The symposium will cover all aspects of pharmaceutical and biomedical analysis, including new analytical technologies and methodologies for (bio) pharmaceuticals, biomarkers, and “omics”. A particular emphasis will be placed on natural products, especially traditional Chinese medicines.
The purpose of PBA 2016 is to bring together people from industry, universities, control laboratories, and hospitals to discuss the current status of analytical techniques, including instrumental applications and theoretical developments. The symposium will also host internationally recognized speakers to present plenary and keynote lectures. Selected papers will be presented as oral communications with preference given to poster presentations.
A number of workshops are organized and will focus on topics such as pharmaceutical analysis and how to write a scientific paper. An extensive exhibition of instrumentation, accessories, and supplies will also run in parallel to the scientific programme. In order to encourage scientific exchange and network building, PBA also hosts an attractive programme of social events including a welcome reception, evening banquet, and farewell cocktails.
Abstracts are currently being accepted for consideration for both lectures and posters, and can be submitted on-line at www.pba2016.org/page/386.html. All abstracts will be reviewed on the basis of scientific merit, novelty, and practical application. Presenters at the meeting may also have their work published in a Virtual Special Issue (VSI) of the Journal of Pharmaceutical and Biomedical Analysis, which is dedicated to the PBA 2016.
An award will be given for “The Best Oral Presentation by Young Scientist at PBA 2016” dedicated to the 110th Anniversary of Jinan University, sponsored by Shimadzu. Scientists under the age of 35 will be eligible and the award will be decided based upon lecture presentations at the Young Scientists Session. The winner of the prize will receive a $500 cash award and free registration for the PBA 2017 Symposium to be held in Spain. Ten poster presentation awards will also be given by an international jury of leading experts in the field of pharmaceutical and biomedical analysis. For more information please visit www.pba2016.org/page/381.html.
A sprawling port city located on the banks of the Pearl River, Guangzhou is the economic centre of southern China and one of the most important centres of foreign commerce. As China’s third largest city with a population of 6.7 million, Guangzhou has plenty to offer from a towering commercial metropolis to beautiful and evergreen scenery. Often cited as the birthplace of “Dim Sum”, the city has a worldwide reputation for good food containing more restaurants and teahouses that any other city in China. Guangzhou is a wonderful city and we look forward to welcoming you here in November for PBA 2016!
E-mail:pba2016@hotmail.com • Website:www.pba2016.org
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
